Chromium, Glucose Intolerance and Diabetes

REFERENCES

• National Research Council: “Recommended Dietary Allowance,” 10 ed. Washington, DC: National Academy Press, 1989.
   Google Scholar
• Anderson RA: Recent advances in the clinical and biochemical effects of chromium deficiency. In Prasad AS (ed): “Essential and Toxic Trace Elements in Human Health and Disease.” New York: Wiley Liss, pp 221–234, 1993.
   Google Scholar
• Anderson RA: Chromium, glucose tolerance, diabetes and lipid metabolism. J Adv Med 8: 37–49, 1995.
   Google Scholar
• Mertz W: Chromium in human nutrition: a review. J Nutr 123: 626–633, 1993.
   PubMed Web of Science ®Google Scholar
• Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A: Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30: 531–538, 1977.
   PubMed Web of Science ®Google Scholar
• Freund H, Atamian S, Fischer JE: Chromium deficiency during total parenteral nutrition. JAMA 241: 496–498, 1979.
   PubMed Web of Science ®Google Scholar
• Brown RO, Forloines-Lynn S, Cross RE, Heizer WD: Chromium deficiency after long-term total parenteral nutrition. Dig Dis Sci 31: 661–664, 1986.
   PubMed Web of Science ®Google Scholar
• Anderson RA: Chromium and parenteral nutrition. Nutrition 11: 83–86, 1995.
   PubMed Web of Science ®Google Scholar
• Borel JS, Majerus TC, Polansky MM, Moser PB, Anderson RA: Chromium intake and urinary chromium excretion of trauma patients. Biol Trace Elem Res 6: 317–326, 1984.
   PubMed Web of Science ®Google Scholar
• Anderson RA: Essentiality of chromium in humans. Sci Total Environ 86: 75–81, 1989.
   PubMed Web of Science ®Google Scholar
• American Medical Association Department of Foods and Nutrition: Guidelines for essential trace element preparations for parenteral use. A statement by an expert panel. JAMA 241: 2051–2054, 1979.
   PubMed Web of Science ®Google Scholar
• Fleming CR: Trace element metabolism in adult patients requiring total parenteral nutrition. Am J Clin Nutr 49: 573–579, 1989.
   PubMedGoogle Scholar
• Green HL, Hambidge KM, Schankler R: Guidelines for the use of vitamins, trace elements, calcium, magnesium and phosphorus in infants and children receiving total parenteral nutrition: report of the subcommittee on pediatric parenteral nutrient requirements from the committee on clinical practice issues of the American Society for Clinical Nutrition. Am J Clin Nutr 48: 1324, 1988.
   PubMed Web of Science ®Google Scholar
• Verhage AH, Cheong WK, Jeejeebhoy KN: Neurologic symptoms due to possible chromium deficiency in long-term parenteral nutrition that closely mimic metronidazole-induced syndrome. JPEN 20: 123–127, 1996.
   PubMed Web of Science ®Google Scholar
• Bougle D, Bureau F, Deschrevel G, Hecquard C, Neuville D, Drosdowsky M, Duhamel JF: Chromium and parenteral nutrition in children. J Pediat Gastr Nutr 17: 72–74, 1993.
   PubMedGoogle Scholar
• Moukarzel AA, Song MK, Buckman AL, Vargas J, Gass W, McDirmid S, Reyen L, Ament M: Excessive chromium intake in children receiving total parenteral nutrition. Lancet 339: 385–388, 1992.
   PubMedGoogle Scholar
• Anderson RA, Bryden NA, Patterson KY, Veillon C, Andon M, Moser-Veillon P: Breast milk chromium and its association with chromium intake, chromium excretion, and serum chromium. Am J Clin Nutr 57: 519–523, 1993.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics: Commentary on breast feeding and infant formulas including proposed standards for formulas. Pediatrics 57: 278–285, 1976.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Kozlovsky AS: Chromium intake, absorption and excretion of subjects consuming self-selected diets. Am J Clin Nutr 41: 1177–1183, 1985.
   PubMed Web of Science ®Google Scholar
• Cauwenbergh RV, Hendrix P, Robberecht H, Deelstra HA: Daily dietary chromium intake in Belgium, using duplicate portion sampling. Z Lebenson Unters Forsch 203: 203–206, 1996.
   PubMedGoogle Scholar
• Anderson RA, Bryden NA, Polansky MM: Dietary chromium intake - freely chosen diets, institutional diets and individual foods. Biol Trace Elem Res 32: 117–121, 1992.
   PubMed Web of Science ®Google Scholar
• Offenbacher KG, Rinko CJ, Pi-Sunyer X: The effects of inorganic chromium and brewer’s yeast on glucose tolerance, plasma lipids and plasma chromium in elderly subjects. Am J Clin Nutr 42: 454–461, 1985.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Polansky MM, Bryden NA, Roginski EE, Mertz W, Glinsmann W: Chromium supplementation of human subjects: effects on glucose, insulin and lipid parameters. Metabolism 32: 894–899, 1983.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Polansky MM, Bryden NA, Bhathena SJ, Canary J: Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metabolism 36: 351–355, 1987.
   PubMed Web of Science ®Google Scholar
• Clausen J: Chromium induced clinical improvement in symptomatic hypoglycemia. Biol Trace Elem Res 17: 229–236, 1988.
   PubMedGoogle Scholar
• Anderson RA, Polansky MM, Bryden NA, Canary J: Supplemental-chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets. Am J Clin Nutr 54: 909–916, 1991.
   PubMed Web of Science ®Google Scholar
• Abraham AS, Brooks BA, Eylath U: The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism 41: 768–771, 1992.
   PubMed Web of Science ®Google Scholar
• Sherman L, Glennon JA, Brech WJ, Klomberg GH, Gordon ES: Failure of trivalent chromium to improve hyperglycemia in diabetes mellitus. Metabolism 17: 439–442, 1968.
   PubMed Web of Science ®Google Scholar
• Rabinowitz MB, Gonick HC, Levine SR, Davidson MB: Clinical trial of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Biol Trace Elem Res 5: 449–466, 1983.
   PubMed Web of Science ®Google Scholar
• Uusitupa MIJ, Kumpulainen JT, Voutilainen E, Hersio K, Sarlund H, Pyorala KP, Koivistoinen P, Lehto JT: Effect of inorganic chromium supplementation on glucose tolerance, insulin response and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr 38: 404–410, 1983.
   PubMed Web of Science ®Google Scholar
• Mossop RT: Effects of chromium (III) on fasting glucose, cholesterol and cholesterol HDL levels in diabetics. Cent Afr J Med 29: 80–82, 1983.
   PubMedGoogle Scholar
• Nath R, Minocha J, Lyall V, Sunder S, Kumar V, Kapoor S, Dhar KL: Assessment of chromium metabolism in maturity onset and juvenile diabetes using chromium-51 and therapeutic response of chromium administration on plasma lipids, glucose tolerance and insulin levels. In Shapcott D, Hubert J (eds): “Chromium in Nutrition and Metabolism.” Amsterdam: Elsevier/North Holland, pp 213–222, 1979.
   Google Scholar
• Glinsmann W, Mertz W: Effect of trivalent chromium on glucose tolerance. Metabolism 15: 510–520, 1966.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Bryden NA, Polansky MM, Gautschi K: Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats. J Trace Elem Exper Med 9: 11–25, 1996.
   Google Scholar
• Evans GW: The effect of chromium picolinate on insulin controlled parameters in humans. Int J Biosoc Med Res 11: 163–180, 1989.
   Google Scholar
• Ravina A, Slezak L, Rubal A, Mirsky N: Clinical use of the trace element chromium (III) in the treatment of diabetes mellitus. J Trace Elem Exper Med 8: 183–190, 1995.
   Google Scholar
• Anderson RA, Cheng N, Bryden NA, Polansky MM, Chi J, Feng J: Beneficial effects of chromium for people with diabetes. Diabetes 46: 1786–1791, 1997.
   PubMed Web of Science ®Google Scholar
• Jovanovic-Peterson L, Gutierry M, Peterson CM: Chromium supplementation for gestational diabetic women (GDM) improves glucose tolerance and decreases hyperinsulinemia. Diabetes 43: 337a, 1996.
   Google Scholar
• Anderson RA: Stress effects on chromium nutrition of humans and farm animals. In Anonymous (ed): “Proc Alltech’s Tenth Symposium Biotechnology in the Feed Industry.” Nottingham, England: Univ Press, pp 267–274, 1994.
   Google Scholar
• Uusitupa MIJ, Mykkanen L, Siitonen O, Laakso M, Sarlund H, Kolehmainen P, Rasanen T, Kumpulainen J, Pyorala K: Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Br J Nutr 68: 209–216, 1992.
   PubMed Web of Science ®Google Scholar
• Saad MJA: Molecular mechanisms of insulin resistance. Brazilian J Med Biol Res 27: 941–957, 1994.
   PubMed Web of Science ®Google Scholar
• Kahn CR: Current concepts of the molecular mechanism of insulin action. Ann Rev Med 36: 429–451, 1985.
   PubMed Web of Science ®Google Scholar
• Okaka T, Sakuma L, Fukui Y, Hageki O, Ui M: Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmanin as a result of selective inhibition of phosphatidylinositol kinase. J Biol Chem 269: 3563–3567, 1994.
   PubMed Web of Science ®Google Scholar
• Kanai F, Ito K, Todaka M, Hayashi O, Kamohara S, Ishii K, Okada T, Kakakie O, Ui M, Ebina Y: Insulin-stimulated glut 4 translocation is relevant to the phosphorylation of IRS 1 and the activity of PI3-kinase. Biochem Biophys Res Comm 195: 762–768, 1993.
   PubMedGoogle Scholar
• Imparl-Radosevich J, Deas S, Polansky MM, Baedke DA, Ingrebritsen TS, Anderson RA, Graves DJ: Regulation of phosphotyrosine tyrosine phosphatase (PTP-1) and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. Hormone Research (in press).
   Google Scholar
• Roth RA, Lui F, Chin JE: Biochemical mechanisms of insulin resistance. Hormone Res 41(suppl2): 51–55, 1994.
   Google Scholar
• Davis CM, Vincent JB: Chromium oligopeptide activates insulin receptor kinase activity. Biochemistry 36: 4382–4385, 1997.
   PubMed Web of Science ®Google Scholar
• Davis CM, Sumall KH, Vincent JB: A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP). Biochemistry 35: 12963–12969, 1996.
   PubMed Web of Science ®Google Scholar
• Potter JF, Levin P, Anderson RA, Freiberg JM, Andres R, Elahi D: Glucose metabolism in glucose-intolerant older people during chromium supplementation. Metabolism 34: 199–204, 1985.
   PubMed Web of Science ®Google Scholar
• Mertz W, Abernathy CO, Olin SS: Risk Assessment of Essential Elements, Washington, DC: ILSI Press, pp xix–xxxviii, 1994.
   Google Scholar
• Anderson RA, Bryden NA, Polansky MM: Lack of toxicity of chromium chloride and picolinate. J Am Coll Nutr 16: 273–279, 1997.
   PubMed Web of Science ®Google Scholar
• Doisy RJ, Streeten DHP, Freiberg JM, Schneider AJ: Chromium metabolism in man and biochemical effects. In Prasad AS, Oberleas D (eds): “Trace Elements in Human Health and Disease,” Vol II. Essential and Toxic Elements,” New York: Academic Press, pp 79–104, 1996.
   Google Scholar
• Tuman RW, Bilbo JT, Doisy RJ: Comparison and effects of natural and synthetic glucose tolerance factor in normal and genetically diabetic mice. Diabetes 27: 49–56, 1978.
   PubMed Web of Science ®Google Scholar
• Striffler JS, Law JS, Polansky MM, Bhathena SJ, Anderson RA: Chromium improves insulin response to glucose in rats. Metabolism 44: 1314–1420, 1995.
   PubMedGoogle Scholar
• Yang WZ, Mowat DN, Subiyatno A, Liptrap RM: Effects of chromium supplements on early lactation performance in Holstein cows. Can J Anim Sci 76: 221–230, 1996.
   Google Scholar
• Kegley EB, Spears JW, Brown TT Jr: Immune response and disease resistance of calves fed chromium nicotinic acid complex or chromium chloride. J Dairy Sci 79: 1278–1283, 1996.
   PubMed Web of Science ®Google Scholar
• Kozlovsky AS, Moser PB, Reiser S, Anderson RA: Effects of diets high in simple sugars on urinary chromium losses. Metabolism 35: 515–518, 1986.
   PubMed Web of Science ®Google Scholar
• Hopkins LL Jr, Ransome-Kuti O, Majaj AS: Improvement of impaired carbohydrate metabolism by chromium (III) in malnourished infants. Am J Clin Nutr 21: 203–211, 1968.
   PubMed Web of Science ®Google Scholar
• Levine RA, Streeten DHP, Doisy RJ: Effects of oral chromium supplementation on the glucose tolerance of elderly subjects. Metabolism 17: 114–125, 1968.
   PubMed Web of Science ®Google Scholar
• Carter JP, Kattab A, Abd-El-hadi K, Davies JT, Gholmy AK, Patwardhan VN: Chromium (III) in hypoglycemia and impaired glucose utilization in kwashiorkor. Am J Clin Nutr 21: 195–202, 1968.
   PubMedGoogle Scholar
• Gurson CT, Saner G: Effect of chromium on glucose utilization in marasmic protein-calorie malnutrition. Am J Clin Nutr 24: 1313–1319, 1971.
   PubMed Web of Science ®Google Scholar
• Offenbacher KG, Pi-Sunyer X: Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes 29: 919–925, 1980.
   PubMed Web of Science ®Google Scholar
• Riales R, Albrink MJ: Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high density lipoprotein of adult men. Am J Clin Nutr 34: 2670–2678, 1981.
   PubMed Web of Science ®Google Scholar
• Martinez OB, MacDonald AC, Gibson RS, Bourn O: Dietary chromium and effect of chromium supplementation on glucose tolerance of elderly Canadian women. Nutr Res 5: 609–620, 1985.
   Web of Science ®Google Scholar
• Bourn DM, Gibson RS, Martinez OB, MacDonald AC: The effect of chromium supplementation on serum lipids in a selected sample of Canadian postmenopausal women. Biol Trace Elem Res 9: 197–205, 1986.
   Web of Science ®Google Scholar
• Urberg M, Zemmel MB: Evidence for synergism between chromium and nicotinic acid in the control of glucose tolerance in elderly humans. Metabolism 36: 896–899, 1987.
   PubMed Web of Science ®Google Scholar
• Urberg M, Benyi J, John R: Hypocholesterolemic effects of nicotinic acid and chromium supplementation. J Fam Pract 27: 603–606, 1988.
   PubMedGoogle Scholar
• Wang MM, Fox EA, Stoecker BJ, Menendez CE, Chan SB: Serum cholesterol of adults supplemented with brewer’s yeast or chromium chloride. Nutr Res 9: 989–998, 1989.
   Web of Science ®Google Scholar
• Press RI, Geller J, Evans GW: The effect of chromium picolinate on cholesterol and apolipoprotein fractions in human subjects. West J Med 152: 41–45, 1990.
   PubMedGoogle Scholar
• Lefavi RG, Wilson GD, Keith RE, Anderson RA, Blessing DL, Hames CG, McMillan JL: Lipid lowering effect of dietary chromium (III)-nicotinic acid complex in male athletes. Nutr Res 13: 239–249, 1993.
   Web of Science ®Google Scholar
• Roeback JR Jr, Mae K, Chambless LE, Fletcher RH: Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. Ann Intern Med 115: 917–924, 1991.
   PubMed Web of Science ®Google Scholar
• Wilson BE, Gondy A: Effect of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. Diabetes Res Clin Prac 28: 179–184, 1995.
   PubMed Web of Science ®Google Scholar
• Thomas VLK, Gropper SS: Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors. Biol Trace Elem Res 55: 297–305, 1997.
   Google Scholar
• Elias AN, Grossman MK, Valenta LJ: Use of the artificial beta cell (ABC) in the assessment of peripheral insulin sensitivity; effect of chromium supplementation in diabetic patients. Gen Pharmacol 15: 535–539, 1984.
   PubMedGoogle Scholar
• Lee NA, Reasner CA: Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 17: 1449–1452, 1994.
   PubMedGoogle Scholar